@ThereAbouts Your post sounds like misinformation to me and I note your sentiment is 'none' and disclosure is 'not held'.
@leaningeachdy Thank you for the informative link, the 'conclusion' below speaks volumes about IVM.
Here is another link: Ivermectin and Covid-19: how a cheap antiparasitic became political (pharmaceutical-technology.com)
Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials (IDSA, 28 June 2021)
Cell Therapy News/Articles, page-9850
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.83%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.10 | $1.03 | $4.925M | 4.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7260 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 67541 | 7 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |